Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Chronic Lymphocytic Leukaemia (CLL), confirmed through a blood test called flow cytometry — this includes people who have never been treated, are currently receiving treatment, or have already completed treatment
- People who have been diagnosed with Monoclonal B-cell Lymphocytosis (MBL), a condition where a small number of abnormal blood cells are present but not at levels that require treatment
- Healthy people of a similar age to those with CLL or MBL, who are being included for comparison purposes
- Healthy people aged over 40 who are being included as a younger comparison group
Who may not be able to join:
- People who are under 40 years of age
- Healthy people being considered as control participants who have a diagnosis of CLL or MBL
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effects of MBL on bone marrow function; Effects of CLL on bone marrow function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.